We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > clinical trial

News List

Failed Clinical Trial: Menlo's Stock Tanks biospace
April 10, 2018
Menlo Therapeutics' stock dropped 55 percent in premarket trading after announcing its serlopitant failed to meet primary and secondary endpoints in a Phase II clinical trial.
First Patient Enrolled in Cavion Multi-Center Phase 2 Clinical Trial in Epilepsy biospace
March 21, 2018
Cavion, Inc. announced today that the first patient has been enrolled in its innovative T-WAVE Phase 2a proof-of-concept clinical trial (NCT03406702).
Trovagene Announces Activation of First Clinical Trial Site in AML Trial americanpharmaceuticacreview
November 14, 2017
Trovagene announced the activation of its clinical trial site for its Phase 1b/2 multicenter trial of PCM-075 in patients with AML, with Virginia Cancer Specialists and Principal Investigator, Dr. Alexander Spira.